PDE4A and cancer: PDE4 inhibitors have emerged as promising therapeutic agents in cancer treatment due to their ability to elevate cAMP levels, a second messenger that influences numerous signaling pathways involved in cell proliferation, apoptosis, and inflammation [7,96].